Patent Application Titled "Ectonucleotide Pyrophosphatase-Phosphodiesterase-1 (Enpp1) Inhibitors And Uses Thereof" Published Online (USPTO 20240352046).

A patent application titled "Ectonucleotide Pyrophosphatase-Phosphodiesterase-1 (Enpp1) Inhibitors And Uses Thereof" was published online on October 24, 2024, by inventors from various locations. The application focuses on the role of ENPP1 in DNA damage repair, immune responses, and cancer progression. It proposes compounds and methods for inhibiting ENPP1 to treat cancer and other diseases associated with this enzyme. The patent application highlights the potential of ENPP1 inhibitors as a novel therapeutic approach in cancer treatment. [Extracted from the article]